Glexia Pharma Private Limited
About Glexia Pharma Private Limited
Data last updated:
Glexia Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21001DL2016PTC299140. Its GSTIN is 07AAGCG4168G1ZJ (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anmol Nagpal and Rajat Ahuja.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Property No.504/3 – A/4 Built On Part Of Plot No.97, Block No.26. Gali No.10 Main Pandav Road Vishwas Nagar, New Delhi, Delhi, India – 110032.
As per the financials filed for FY 2020, the company reported a revenue of ₹7.85 Lakh, a decline of 30% compared to the previous year. For the same year it recorded a net loss of ₹17.54 Lakh (net margin -223.3%) and EBITDA of -₹8.62 Lakh (EBITDA margin -109.8%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Glexia Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U21001DL2016PTC299140, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21001DL2016PTC299140 | Current |
| U74999DL2016PTC299140 | Previous |
| U47912DL2016PTC299140 | Previous |
Contact details
Glexia Pharma Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressProperty No.504/3 – A/4 Built On Part Of Plot No.97, Block No.26. Gali No.10 Main Pandav Road Vishwas Nagar, New Delhi, Delhi, India – 110032
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Glexia Pharma Private Limited
FY 2024 filings availableGlexia Pharma Private Limited reported revenue of ₹7.85 Lakh (down 30% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 30% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 7%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹7.85 Lakh | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹8.62 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹17.54 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -109.8% | |||
| Net Profit Margin | -223.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Glexia Pharma Private Limited, buy the company report.
Board of directors of Glexia Pharma Private Limited
Glexia Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anmol Nagpal Also directs: Carexpo Technology Private Limited | Director | 31 Jul 2024 | 2 Years 3 Months | Current |
| Rajat Ahuja | Director | 05 May 2016 | 10 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Glexia Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glexia Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Glexia Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGCG4168G1ZJ | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Glexia Pharma Private Limited, buy the company report.
Recent activity
Glexia Pharma Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Anmol Nagpal was appointed as Director on 31 Jul 2024.
Frequently asked questions
Glexia Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 May 2016 (10+ years old) and is registered under CIN U21001DL2016PTC299140.
Glexia Pharma has 2 current directors:
- Anmol Nagpal - Director
- Rajat Ahuja - Director
The latest financial statements of Glexia Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Glexia Pharma is 07AAGCG4168G1ZJ, registered in Delhi.
The CIN (Corporate Identification Number) of Glexia Pharma is U21001DL2016PTC299140. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glexia Pharma was incorporated on 05 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
Anmol Nagpal was appointed as Director on 31 Jul 2024. Lokender Kumar ceased to be Director on 31 Jul 2024. Rajat Ahuja was appointed as Director on 05 May 2016.
The registered office of Glexia Pharma is at Property No.5043 – A4 Built On Part Of Plot No.97, Block No.26. Gali No.10 Main Pandav Road Vishwas Nagar, New Delhi, Delhi, India – 110032.
Glexia Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Glexia Pharma is compliant as of 29 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
